CDK8 remodels the tumor microenvironment and promotes resistance to KRASG12D inhibitors and daraxonrasib in PDAC.
McAndrews KM, Mahadevan KK, Li B, Comptdaer AM, Sockwell AM, Morse SJ, Kelly PJ, Patel SI, Kirtley ML, Moreno Diaz BA, Lyu H, Peng DH, Khazaei S, Schalck A, Zhou X, Sugimoto H, Bickert AA, Sthanam LK, Taylor MR, Kumbhar SV, Arian KA, Barekatain Y, Paradiso F, Guerrero PA, Bernard V, Sobhani N, Camacho-Acevedo AN, Bornes KE, Tran PT, Maitra A, Heffernan TP, Kalluri R.
McAndrews KM, et al. Among authors: kelly pj.
EMBO J. 2026 Jul 11. doi: 10.1038/s44318-026-00854-5. Online ahead of print.
EMBO J. 2026.
PMID: 42436354
Free article.